Overview

Retrospective Evaluation of the Percentage of Subjects Who Have Reached Their LDL-C Objectives After Treatment With INEGY (Study P05103)(COMPLETED)

Status:
Completed

Trial end date:
2008-08-01

Target enrollment:

Participant gender:

Summary

The main objective of this study is to determine the percentage of patients who met the low-density lipoprotein cholesterol (LDL-C) objective with INEGY, that were not under statin monotherapy treatment.

Details

Lead Sponsor:

Merck Sharp & Dohme Corp.

Treatments:

Ezetimibe, Simvastatin Drug Combination